Pharmacodynamic and Pharmacokinetic Study of PL-ASA

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A randomized, open-label, 2-way crossover pharmacodynamic and pharmacokinetic study of a novel pharmaceutical lipid-aspirin complex formulation (PL-ASA) at an 81 mg dose
Epistemonikos ID: b248bba2c0c2739778b507c66c5893f28030e93c
First added on: May 08, 2024